help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokoo, H.
Right arrow Articles by Nakazato, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoo, H.
Right arrow Articles by Nakazato, Y.
(American Journal of Pathology. 2004;164:1717-1725.)
© 2004 American Society for Investigative Pathology

Anti-Human Olig2 Antibody as a Useful Immunohistochemical Marker of Normal Oligodendrocytes and Gliomas

Hideaki Yokoo*, Sumihito Nobusawa*, Hirohide Takebayashi{dagger}, Kazuhiro Ikenaka{dagger}, Koji Isoda*, Makoto Kamiya*, Atsushi Sasaki*, Junko Hirato* and Yoichi Nakazato*

From the Department of Pathology,* Gunma University Graduate School of Medicine, Maebashi; and the Division of Neurobiology and Bioinformatics,{dagger} National Institute for Physiological Sciences, Okazaki, Japan

Olig2 is a recently identified transcription factor involved in the phenotype definition of cells in the oligodendroglial lineage. The expression of Olig2 transcript has been demonstrated in human oligodendroglial tumors, although the protein expression has not been studied extensively. We developed a polyclonal antibody to human Olig2 and analyzed it immunohistochemically. The antibody depicted a single distinct band of predicted molecular weight by Western blotting, and did not cross-react with human Olig1. In normal human brain tissue, the nuclei of oligodendrocytes of interfascicular, perivascular, and perineuronal disposition were clearly labeled by the antibody. Similarly, the nuclei of oligodendroglial tumors were labeled. There was no apparent correlation between the staining intensity and histological grade. Astrocytic components within the tumors were generally less or not stained. Astrocytic tumors were also positive with the Olig2 antiserum to a lesser extent, and the difference between oligodendroglial and astrocytic tumors was demonstrated by a statistical analysis. Olig2 and glial fibrillary acidic protein were expressed in a mutually exclusive manner, and Olig2 expression was cell-cycle related. Neither central neurocytoma nor schwannoma cases were stained. Our antibody was demonstrated to be useful in recognizing normal oligodendrocytes on paraffin sections, and applicable in diagnosis of some brain tumors.




This article has been cited by other articles:


Home page
 Mol Cancer ResHome page
K. Tabu, Y. Ohba, T. Suzuki, Y. Makino, T. Kimura, A. Ohnishi, M. Sakai, T. Watanabe, S. Tanaka, and H. Sawa
Oligodendrocyte Lineage Transcription Factor 2 Inhibits the Motility of a Human Glial Tumor Cell Line by Activating RhoA
Mol. Cancer Res., October 1, 2007; 5(10): 1099 - 1109.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. C. Clase, D. E. Dimcheff, C. Favara, D. Dorward, F. J. McAtee, L. E. Parrie, D. Ron, and J. L. Portis
Oligodendrocytes Are a Major Target of the Toxicity of Spongiogenic Murine Retroviruses
Am. J. Pathol., September 1, 2006; 169(3): 1026 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
K. Tabu, A. Ohnishi, Y. Sunden, T. Suzuki, M. Tsuda, S. Tanaka, T. Sakai, K. Nagashima, and H. Sawa
A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation.
J. Cell Sci., April 1, 2006; 119(Pt 7): 1433 - 1441.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.